Zdrowie i gospodarka · 07/04/2011
FDA Reorganizes CDER, OSE into Six New Staffs and Abolishes Several Existing Staffs
The FDA has reorganized the CDER, OSE, into six new staffs, including OMEPRM and OPE, and abolished several existing staffs within OSE. The reorganization aims to improve the agency's surveillance and epidemiology capabilities.
Source: Federal Register — Health and Human ServicesOpen original release →